Perforin-dependent CD4 + T-cell cytotoxicity contributes to control a murine poxvirus infection 
CD4
+ T cells are generally regarded as helpers and regulators of the immune response. Although cytolytic CD4 + T cells have been described, whether those generated during the course of a viral infection play a role in virus control remains unknown. Here we show that during acute infection with ectromelia virus, the mouse homolog of the human virus of smallpox, large numbers of CD4 + T cells in the draining lymph node and liver of resistant mice have a cytotoxic phenotype. We also show that these cells kill targets in vivo in a perforin-dependent manner and that mice with specific deficiency of perforin in CD4 + T cells have impaired virus control. Thus, perforin-dependent CD4 + T-cell killing of infected cells is an important mechanism of antiviral defense. + T lymphocytes have been described as helpers and regulators of the immune response, and cytotoxic T lymphocyte (CTL) effector functions have been attributed mostly to CD8 + T cells. However, the existence of MHC II-restricted CD4 + CTL has been recognized since the late 1970s (1) . CD4 + CTL clones have been generated in humans and mice (2, 3) . The presence of CD4 + CTL during primary infection were initially documented in mice that lacked the normal complement of CD8 + T cells (4, 5) or during chronic or persistent viral infections (6, 7) , supporting the notion that CD4 + CTL can be generated by chronic exposure to antigen or repeated in vitro stimulation. However, CD4
+ CTL capable of killing target cells in vivo have been described more recently in immunocompetent mice infected with the Armstrong strain of lymphocytic choriomeningitis virus (LCMV) (8) and with West Nile Virus (9), indicating that CD4 + CTL can also be generated during acute viral infections. CD8 + CTL mainly kill targets by releasing perforin (Prf) and granzymes, such as granzyme B (GzB) through granule exocytosis (GE) (10, 11) . Although human and mouse CD4 + T cells have been shown to lyse cells through Fas-Fas ligand interactions (12) (13) (14) , GE-mediated CD4 + T-cell cytotoxicity has also been shown in human infections with HIV, human cytomegalovirus, Epstein-Barr virus, herpes simplex virus, influenza virus, and vaccinia virus (2, (15) (16) (17) (18) (19) (20) .
Regarding a possible role for CD4 + CTL in protective immunity, previous work by others showed that adoptive transfer of in vitro primed CD4 + CTL protected from lethal influenza infection in a Prf-dependent manner (17) . However, whether CD4 + CTL generated during the course of a viral infection play any role in virus control remains to be demonstrated (3), most likely because it has been difficult to distinguish from the protective effects of CD8 + CTL.
The Orthopoxvirus (OPV) Ectromelia virus (ECTV), the agent of mousepox, has host specificity for the mouse. This virus is very similar to variola virus, the agent of human smallpox, the zoonotic monkeypox virus, and the smallpox vaccine species vaccinia virus (VACV) (21) (22) (23) (24) (25) . Following infection in the footpad, its natural route of entry, ECTV infects the popliteal draining lymph node (D-LN) and spreads through the lymphohematogenous (LH) route to seed visceral organs, mainly the liver and the spleen. Of interest, ECTV LH spread is usually used as the textbook example for the many human and animal natural viruses that, with some variations, spread through the LH route (26, 27) . Although ECTV infects all mouse strains, the outcome of primary infection following footpad inoculation varies. Susceptible strains, such as BALB/c, develop mousepox, which is characterized by uncontrolled replication of the virus in the liver and spleen. Most susceptible mice die with extensive liver damage within the first 14 d postinfection (dpi), and those that survive develop the typical skin rash of poxvirus infections. In resistant strains, such as C57BL/6 (B6), the virus also infects the liver and spleen but the mice do not show overt symptoms of disease because the replication of the virus is controlled by the combined action of innate and adaptive immune mechanisms (21, 23, 25, (28) (29) (30) (31) (32) (33) .
Our previous studies and those of others have shown that CD4 + T-cell help-independent CD8 + T-cell responses are essential for the early-and that CD4 + T-cell help-dependent Ab responses are essential for the late but not the early-control of primary ECTV infections (29, (34) (35) (36) . Previous work suggested that, in addition to providing help to B cells, CD4 + T cells may also have a direct effector function to control ECTV but the specific mechanism was not identified (31 CD11a and CD49d coexpression marks activated CD4 + T cells induced by antigen exposure (37, 38) . When we determined the CD4 + T-cell response to ECTV in C57BL/6 (B6) mice using these markers, we found that at 5 dpi ∼60% of the CD4 + T cells in the D-LN were CD11a + CD49d + , indicating strong virusspecific CD4 + T-cell responses. Interestingly, ∼60% of the CD11a + CD49d + CD4 + T cells were also GzB + (Fig. 1A) . In the reverse analysis, ∼95% of the GzB + CD4 + T cells were CD11a + CD49d + , indicating that GzB expression occurs only in antigen experienced cells (Fig. 1B) . At 7 dpi, ∼70% of the CD4 + T cells in the D-LN and liver were CD11a + CD49d + and ∼60% of these were GzB + . In the spleen ∼40% were CD11a + CD49d + and 40% of these were GzB + but the reverse analysis showed that the majority of the GzB + but not of the GzB − CD4 + T cells in all organs were CD11a + CD49d + (Fig. S1A) . When the total CD4 + T cells were considered, ∼40% in the D-LN but low background frequencies in the liver or spleen were GzB + at 5 dpi, and 40% in the D-LN and liver and 15% in the spleen were GzB + at 7 dpi; however, the absolute number of GzB + cells was higher in the spleen than in the other organs (Fig. 1C) .
To further address the extent of the CD4 + T-cell response to ECTV, we inoculated B6 mice at different stages of infection with BrdU intraperitoneally. Three hours later, proliferation by BrdU incorporation was determined by flow cytometry in various organs. BrdU incorporation by CD4 + T cells peaked at 5 dpi and remained high at 7 dpi in the D-LN. Incorporation of BrdU in spleen and liver was low at 5 dpi but increased significantly at 7 dpi. Of interest, the proliferative response was higher in the D-LN and liver than in the spleen. More important, most of the CD4 + T cells that incorporated BrdU + expressed GzB (Fig. S1B). We also found that CD4 + T cells from mice at 7 dpi and exposed to infected cells ex vivo expressed surface CD107a, a sign of degranulation (Fig. S1C) . Thus, the CD4 + T-cell responses to ECTV are large, particularly in the D-LN and liver and, consistent with a CTL phenotype, most of the responding CD4 + T cells are GzB + .
VACV MHC II-Restricted CD4 + T-Cell Determinant I1L [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] Is also an ECTV Determinant. To identify ECTV CD4 + T-cell determinants, we screened B6 mice for responses to the previously described VACV determinants H3L 272-286 , I1L [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , and B5 [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] (39, 40) , which are highly conserved in ECTV. Compared with uninfected mice, a significantly larger proportion of the splenic CD4 + T cells from infected mice stained with I-Ab-I1L 7-21 (QLVFNSISAR-ALKAY in VACV and the tetramer; QLIFNSISARALKAY in ECTV, bold underlined letters indicate a different amino acid between VACV and ECTV) but not with tetramers loaded with H3L 272-286 , B5 46-60 or control CLIP peptide (Fig. S2A) . In addition, a small but clear population of splenic CD4 + T cells from infected mice produced IFN-γ when stimulated in vitro with the ECTV variant of I1L [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] (Fig. S2B) . Moreover, more CD4 + T cells stained with I-A b -I1L 7-21 at 5 dpi in the D-LN and at 7 dpi in the liver in infected compared with uninfected mice (Fig. 2A) . Furthermore, there was a significantly higher number of I1L [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] but not H3L 272-286 specific CD4 + T cells in the spleens and livers at 5 and 7 dpi compared with uninfected mice in ELISPOT assays ( Fig. 2B and Fig. S2C ). Hence, the VACV CD4 + T-cell determinant I1L 7-21, (39) (Fig. 3B) . At 5 dpi, MHC II-restricted in vivo killing of target cells pulsed with the I1L 7-21 peptide was observed in the D-LN but not in the liver or spleen (Fig. 3C) . However, strong MHC II-restricted specific killing was observed in the liver and to a lesser extent in the spleen and nondraining lymph node (ND-LN) at 7 dpi. Thus, the in vivo killing of MHC II-restricted I1L 7-21 pulsed targets was consistent with the frequencies of GzB + CD4 + T cells in the different organs and with the kinetics of their response.
In addition to GzB, killing by GE requires Prf. Although GzBdeficient mice are not readily accessible, Prf-deficient (Prf −/− ) mice can be obtained commercially. Thus, we compared MHC II-restricted killing of targets pulsed with I1L [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] in the livers of B6 and Prf −/− mice infected with ECTV. Because Prf −/− mice are highly susceptible to mousepox, all groups were treated with the poxvirus inhibitor Cyodofovir at 4 dpi. We found that killing was absent in the Prf −/− mice, indicating that during ECTV infection, MHC IIrestricted killing in vivo depends on the GE pathway (Fig. 3D) . (Fig. 4A) . Furthermore, although production of Abs to ECTV requires CD4 + T-cell help and anti-ECTV Abs are required for long-term survival to mousepox, the control of ECTV at 7 dpi is completely independent of Abs (34, 36) . To determine whether the effector function of CD4 + T cells is required for efficient virus control, we measured virus titers at 7 dpi in B6 mice depleted of CD4 + T cells, CD8 + T cells, CD4 + and CD8 + T cells, and in MHC II −/− mice. The virus titers in the liver and spleen of the CD4 + T-cell-depleted or MHC II −/− mice were 10-to 100-fold higher than in intact B6 mice, but lower than in B6 mice depleted of CD8 + T cells. Depletion of CD4 + and CD8 + T cells resulted in significantly higher virus titers in the spleen compared with any single depletion (Fig. 4B) . Thus, although CD8
+ T cells appear to be more efficient, the effector functions of CD4 + significantly contribute to control ECTV loads. We also compared virus titers in CD4 + T-cell-depleted, as well as CD4
−/− and CD8
, mice to those of CD40 −/− and Bcell-deficient mice, which are unable to make Ab responses but mount normal CD4 + and CD8 + T-cell responses (34) . Confirming the preponderance of effector CD8 + T cells but also the significant contribution of effector CD4 + T cells to ECTV control, we found no differences in the virus titers between CD40 −/− , B-cell-deficient, and wild-type B6 mice. However, there were 10-to 100-fold higher virus titers (measured only in spleens) (Fig.  4C ) of CD4 + T-cell-depleted or CD4 −/− mice compared with wild-type B6 mice, and even higher virus loads in CD8 −/− mice. When tested for survival, CD8
−/− mice succumbed ∼7 dpi because of lack of early virus control by CD8 + T cells; B-cell-deficient mice and CD40 −/− mice succumbed more than 40 dpi. On the other hand, MHC II −/− mice succumbed ∼20 dpi, indicating that in addition to their ability to provide help to B cells, CD4 + T cells have a direct role in controlling ECTV (Fig. 4D) .
Prf Deficiency Exclusively in CD4 + T Cells Results in Deficient ECTV
Control. To investigate whether CD4 + CTL are required to efficiently control ECTV, we depleted B6 mice of CD4 + T cells, harvested their splenocytes, mixed them with magnetically purified CD4 + T cells from B6 or Prf −/− mice in an 84:16 ratio, and transferred them into SCID B6 mice. Two weeks after reconstitution, the mice had normal proportions of CD4 + and CD8 + T cells in the blood (Fig. 5A) . Three weeks after reconstitution, the mice were challenged with ECTV. At 7 dpi, a similarly large proportion of CD4 + T cells in the livers of the reconstituted SCID and control B6 mice expressed GzB (it should be noted that there are no good commercial Abs to identify Prf + cells by flow cytometry) (Fig. 5B) . However, the virus titers in the liver and spleen of SCID mice reconstituted with Prf −/− CD4 + T cells were significantly higher than in mice reconstituted with wild-type CD4 + T cells (Fig. 5C ). Thus, in mice that had a specific deficiency of Prf in CD4 + T cells, the control of ECTV was defective. These data are unique in demonstrating that CD4 + CTL generated during the course of a viral infection play a significant role in controlling the virus.
Discussion
Previous studies in mousepox-resistant B6 mice suggested that in addition to their helper functions, CD4 + T cells may have an effector role in controlling ECTV infection (31) . At the time, the authors did not investigate the mechanism but proposed it did not involve cytotoxicity. Here we found that the CD4 + T-cell responses to ECTV are very strong and dominated by cells that express GzB, in particular in the D-LN and liver, where at the peak of the response they reached ∼40% of the total CD4 + T cells. To our knowledge, such extensive expression and tissue compartmentalization of a cytolytic molecule in CD4 + T cells during a viral infection has not been documented.
The large proportion of GzB + CD4 + T cells that we detected in the D-LN and liver also suggested that CD4 + T-cell responses might be more extensive than generally thought. Our analysis of the kinetics of the CD4 + T-cell response by BrdU incorporation confirmed that the CD4 + T-cell responses are massive in the D-LN and liver but smaller in the spleen. Our results also indicated that the majority of the responding CD4 + T cells (CD11a + CD49d + ) are GzB + in the D-LN and liver and, to a smaller extent, also in the spleen. Although it is commonly thought that the antiviral CD4 + T-cell responses are quantitatively much smaller than those of CD8 + T cells, our data are consistent with a recent report suggesting that CD4 + T-cell responses are much larger than previously appreciated and showing that the anti-LCMV CD4 + T-cell responses detected in peripheral blood lymphocytes comprised 50% of the CD4 + T cells (38) . Nevertheless, the CD4 + T-cell responses to I1L [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] , the most dominant determinant in our experiments and which is also the most dominant determinant yet indentified for VACV (39) , consisted of no more than 1.5% of the total CD4 + T cells. This finding contrasts with the CD8 + T-cell response where 5-8% of the total CD8 + T cells are directed toward the dominant determinant B8R [20] [21] [22] [23] [24] [25] [26] [27] (35, 41) . One possibility is that for CD4 + T cells, the total response spreads among a much broader set of determinants. Alternatively, the dominant determinant may remain to be discovered.
The existence of CD4 + CTL in humans and mice is well documented (2, 3) . Furthermore, it has been shown that ex vivo generated CD4 + CTL can protect mice from influenza virus infection (17 (26) . Thus, it is very possible that the cytolytic activity of the CD4 + T cells also plays a role in their control. Thus, our results have important implications for our understanding of the functions of the immune system. Moreover, because CD4 + CTL are so prevalent, the ECTV model offers a tractable system to identify the molecular mechanisms that result in their induction in vivo and this may be important for the development of novel vaccines. Infections. For infections, sex-matched 8-to 12-wk-old animals were used. Mice were infected in the left footpad with 25 μL PBS containing 3 × 10 3 pfu unless otherwise indicated. When indicated, 400 μg cidofovir (Vistide) was injected 4 dpi intraperitoneally.
Cell Culture, ECTV Moscow, Virus Production, and Determination of Virus Titers. Cell culture, ECTV Moscow, virus production, and determination of virus titers were done as described previously (42) . ECTV-OVA197-386-IRES-EGFP was produced by homologous recombination as described previously (43) by introducing a C-terminal fragment of chicken ovalbumin coding for amino acids 197-386, followed by the internal ribosomal entry site from Encephalomyocarditis virus in front of EGFP.
Flow Cytometry. BrdU incorporation, isolation of liver lymphocytes, and intracellular staining was done as described previously (34, 42, 43 At least 100,000 cells were analyzed by flow cytometry using a LSR II system (BD Biosciences). Data Displayed and Statistical Analysis. Unless indicated, all displayed data correspond to one representative experiment of at least three similar experiments with groups of three to five mice. When indicated, the LNs, livers, and spleens from the mice in a group were pooled. Statistical analysis was performed using Prism (GraphPad Software) software. For survival studies, P values were obtained using the Log-rank (Mantel-Cox) test. All other statistical analyses were performed using an unpaired two-tailed Student t test or the Mann-Whitney test as applicable. When applicable, data are displayed with mean ± SEM.
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